PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan ioosawa-tky@umin.ac.jp.\', \'Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.\', \'TXP Medical Co. Ltd, Bunkyo-ku, Tokyo, Japan.\', \'Viatris Pharmaceuticals Japan Inc, Shibuya-ku, Tokyo, Japan.\', \'EPS Corporation, Shinjuku-ku, Tokyo, Japan.\', \'MinaCare Co., Ltd, Chiyoda-ku, Tokyo, Japan.\', \'Division of General Internal Medicine and Health Service Research, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.\', \'Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2021-050938
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 34301667
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Physician visits and medication prescriptions for major chronic diseases during the COVID-19 pandemic in Japan: retrospective cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all